Dilara Akhoundova
- Oncology top 10%
- CAR-T cell therapy research 7
- Pancreatic and Hepatic Oncology Research 4
- Cancer Immunotherapy and Biomarkers 4
-
- Cancer Genomics and Diagnostics 10
-
- Lung Cancer Treatments and Mutations 9
-
- Multiple Myeloma Research and Treatments 6
-
- Genetic factors in colorectal cancer 6
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
- Co-authors
- Mark A. RubinThomas PabstUlrike BacherMichael DaskalakisKatja SeipelRalph FritschGertrud WiedemannNaomi Porret
- Partner nations
- SwitzerlandSpainUnited States
In The Last Decade
Dilara Akhoundova
42 papers receiving 421 citations
Peers
Comparison fields: 5 of 50
- Oncology 247
- Cancer Research 113
- Pulmonary and Respiratory Medicine 118
- Hematology 38
- Pathology and Forensic Medicine 42
Countries citing papers authored by Dilara Akhoundova
This map shows the geographic impact of Dilara Akhoundova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dilara Akhoundova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dilara Akhoundova more than expected).
Fields of papers citing papers by Dilara Akhoundova
This network shows the impact of papers produced by Dilara Akhoundova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dilara Akhoundova. The network helps show where Dilara Akhoundova may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dilara Akhoundova, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 3 | |
| 8 | 2023 | 40 | |
| 9 | 2023 | 7 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 35 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 1 | |
| 14 | 2023 | 23 | |
| 15 | 2022 | 16 | |
| 16 | 2021 | 9 | |
| 17 | 2020 | 2 | |
| 18 | 2018 | 2 | |
| 19 | 2017 | 1 | |
| 20 | 2017 | 13 |
About Dilara Akhoundova
Dilara Akhoundova is a scholar working on Oncology, Cancer Research and Hematology, having authored 45 papers that have together received 425 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (10 papers), Lung Cancer Treatments and Mutations (9 papers), CAR-T cell therapy research (7 papers), Multiple Myeloma Research and Treatments (6 papers), Genetic factors in colorectal cancer (6 papers), Pancreatic and Hepatic Oncology Research (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Oncology (247 citations), Cancer Research (113 citations) and Pulmonary and Respiratory Medicine (118 citations). Dilara Akhoundova has collaborated with scholars based in Switzerland, Spain and United States. Frequent co-authors include Mark A. Rubin, Thomas Pabst, Ulrike Bacher, Michael Daskalakis, Katja Seipel, Ralph Fritsch, Gertrud Wiedemann, Naomi Porret, Jorge Aparicio and Robert Díaz Beveridge. Their work appears in journals such as Cancers, Journal of Thoracic Oncology, BMC Cancer, Diagnostic Pathology and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.